Vaxcyte (PCVX) Other Non Operating Income (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Other Non Operating Income data on file, last reported at -$1.4 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$1.4 million, down 119.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.8 million (up 478.57% YoY), and the FY2025 annual result was $37.3 million, up 953.23% from the prior year.
• Other Non Operating Income fell to -$1.4 million in Q1 2026 per PCVX's latest filing, from $1.3 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $28.6 million in Q2 2025 and troughed at -$47.0 million in Q4 2023.
• A 5-year average of -$244588.2 and a median of $235000.0 in 2022 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2024 and 2025: Other Non Operating Income sank 598.42% in 2024, then jumped 6044.73% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $11.2 million in 2022, then plunged by 518.06% to -$47.0 million in 2023, then soared by 75.83% to -$11.4 million in 2024, then surged by 111.65% to $1.3 million in 2025, then slumped by 204.3% to -$1.4 million in 2026.
• Business Quant data shows PCVX's Other Non Operating Income at -$1.4 million in Q1 2026, $1.3 million in Q4 2025, and $291000.0 in Q3 2025.